Amedeo Smart

Free Medical Literature Service

 

Amedeo

Tuberculosis
  Free Subscription

Articles published in
Clin Infect Dis
    February 2026
  1. CAMPBELL JI, Brooks MB, Dankovchik J, Giebultowicz S, et al
    Uncovering household tuberculosis infection testing and care patterns using a novel bioinformatics linkage strategy.
    Clin Infect Dis. 2026 Feb 11:ciag079. doi: 10.1093.
    >> Share

  2. KUHLIN J, Stadler JAM, Grint DJ, Court R, et al
    Treatment adherence with an oral nine-month regimen for rifampicin-resistant tuberculosis in South Africa.
    Clin Infect Dis. 2026 Feb 9:ciag069. doi: 10.1093.
    >> Share

  3. WANG Y, Li R, Cai L, Jin L, et al
    Accuracy of rapid quantitative PCR on tongue swabs for pulmonary tuberculosis in sputum-scarce patients: a prospective multicentre diagnostic study.
    Clin Infect Dis. 2026 Feb 9:ciag071. doi: 10.1093.
    >> Share

  4. GRINT DJ, Dhillon J, Butcher PD, Adams J, et al
    Xpert MTB/RIF Cycle Threshold as a Marker of Tuberculosis (TB) Disease Severity: Implications for TB Treatment Stratification.
    Clin Infect Dis. 2026;82:e126-e134.
    >> Share

  5. DE NOOY A, Omar SV, Ockhuisen T, Zwerling A, et al
    Cost-effectiveness of Targeted Next-Generation Sequencing for Tuberculosis Drug-resistance Testing as an Alternative to the Standard of Care in South Africa.
    Clin Infect Dis. 2026;82:e119-e125.
    >> Share

  6. SOLOVYEVA AV, Volchenkov GV, Ponomarenko OI, Kuznezova TA, et al
    Implementing a Program of Comprehensive Tuberculosis Preventive Treatment: Safety, Effectiveness, and Acceptability of Moxifloxacin or Bedaquiline Use for Contacts Exposed to Drug-Resistant Strains.
    Clin Infect Dis. 2026 Feb 3:ciaf701. doi: 10.1093.
    >> Share

    January 2026
  7. MANZOOR F, Rhee C, Baker MA, Klompas M, et al
    Mycobacterium tuberculosis Transmission in Healthcare Settings: A Systematic Review of Frequency, Risk Factors, and Exposure Conditions.
    Clin Infect Dis. 2026 Jan 30:ciag053. doi: 10.1093.
    >> Share

  8. STARKE S, Thomas K, Jasuja S, Lubelchek R, et al
    Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County, Illinois.
    Clin Infect Dis. 2026 Jan 21:ciaf723. doi: 10.1093.
    >> Share

  9. SWEETSER B, Nguyen H, Dang H, Katumba D, et al
    Evaluating the Cepheid Xpert TB/LTBI research-use-only assay for detection of active and latent Mycobacterium tuberculosis infection.
    Clin Infect Dis. 2026 Jan 21:ciag005. doi: 10.1093.
    >> Share

  10. NIWARD K, Braian C, Svardhagen G, Augustinsson D, et al
    Future Prospects for Using Clinical Phenotypes in Tuberculosis Precision Medicine-An Approach for Clinical Management.
    Clin Infect Dis. 2026 Jan 15:ciaf663. doi: 10.1093.
    >> Share

  11. NALUGWA T, Shah KM, Marcelo D, Nakawunde R, et al
    Predicted Preferences for Tuberculosis Point-of-Care Tests among Tuberculosis-Affected Individuals in Five High Burden Countries.
    Clin Infect Dis. 2026 Jan 14:ciag022. doi: 10.1093.
    >> Share


  12. Correction to: Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2026 Jan 9:ciaf711. doi: 10.1093.
    >> Share

    December 2025
  13. SALAZAR-AUSTIN N, Cohn S, Nonyane BAS, Mulder C, et al
    Effectiveness of a Home-based Approach to Child Contact Investigation and Tuberculosis Preventive Treatment Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial.
    Clin Infect Dis. 2025;81:e385-e392.
    >> Share

  14. MBULI C, Jean Bosco TF, Nsamenang R, Nestor B, et al
    Diagnostic performance of the Pluslife MiniDock MTB and Molbio MTB Ultima assays to detect tuberculosis from tongue and sputum swabs among outpatients and in active case finding in Cameroon.
    Clin Infect Dis. 2025 Dec 23:ciaf709. doi: 10.1093.
    >> Share

  15. MCCREESH N, MacPherson P, Bampi JVB, Engel N, et al
    Reported Tuberculosis Symptoms: An Inadequate Classifier of Disease State.
    Clin Infect Dis. 2025 Dec 10:ciaf611. doi: 10.1093.
    >> Share

  16. DALE KD
    Why we should move away - not towards - symptom-based terminology and policy in tuberculosis.
    Clin Infect Dis. 2025 Dec 5:ciaf667. doi: 10.1093.
    >> Share

    November 2025
  17. NGUYEN HT, Vo LNQ, Codlin AJ, Forse R, et al
    Diagnostic Accuracy of the STANDARD F TB-Feron FIA Assay for Tuberculosis Infection in Vietnam: A Cross-Sectional Study.
    Clin Infect Dis. 2025 Nov 26:ciaf561. doi: 10.1093.
    >> Share

  18. MURRILL MT, Velasquez GE, Szumowski JD, Phillips A, et al
    Tuberculosis infection screening recommendations for targeted immunotherapies: comparison of U.S. prescribing information, clinical resources and quality measures.
    Clin Infect Dis. 2025 Nov 19:ciaf628. doi: 10.1093.
    >> Share

    October 2025
  19. LOVEDAY M, Hughes J, Mchunu N, Yende-Zuma N, et al
    Maternal, pregnancy and infant outcomes in women treated for multidrug/rifampicin-resistant tuberculosis with novel and repurposed drugs in KwaZulu-Natal, South Africa.
    Clin Infect Dis. 2025 Oct 29:ciaf593. doi: 10.1093.
    >> Share

  20. WIJK M, Denti P, Gausi K, Myers B, et al
    Insights into the Role of Rifampicin Exposure and Clinical Baseline Covariates on the Response to Pulmonary Tuberculosis Treatment.
    Clin Infect Dis. 2025 Oct 24:ciaf586. doi: 10.1093.
    >> Share

  21. MINGCHAY P, Kawkitinarong K, Torvorapanit P, Ohata PJ, et al
    Effectiveness of Nebulized Bronchodilator - Enhanced Sputum Induction in Thai Patients with Presumed Pulmonary Tuberculosis; A Randomized Controlled Trial; (NeB-TB Trial).
    Clin Infect Dis. 2025 Oct 23:ciaf580. doi: 10.1093.
    >> Share

  22. MULENGA H, Shenje J, Mendelsohn SC, Luabeya AKK, et al
    Asymptomatic Tuberculosis in Children with Household Exposure to Mycobacterium tuberculosis.
    Clin Infect Dis. 2025 Oct 15:ciaf562. doi: 10.1093.
    >> Share

  23. CHEN SC, Lee YT
    Precision Prevention of Tuberculosis in Biologic Therapy: Lessons Beyond Screening Strategies.
    Clin Infect Dis. 2025 Oct 3:ciaf559. doi: 10.1093.
    >> Share

    September 2025
  24. RUIZ-TAGLE C, Seguel R, Villarroel L, Bernales M, et al
    Reducing Household Tuberculosis Transmission: A Pilot Cluster-Randomized Controlled Trial.
    Clin Infect Dis. 2025 Sep 26:ciaf526. doi: 10.1093.
    >> Share

  25. CHEN SC, Chen CC
    Reassessing Adherence Trajectories in Multidrug-Resistant Tuberculosis: Recovery Advantage and Hidden Biases.
    Clin Infect Dis. 2025 Sep 25:ciaf536. doi: 10.1093.
    >> Share

  26. BROOKS MB, Lecca L, Becerra MC, Calderon RI, et al
    The Role of Youths in Within-Household Tuberculosis Transmission: A Household Contact Cohort Study.
    Clin Infect Dis. 2025 Sep 24:ciaf490. doi: 10.1093.
    >> Share

  27. PEREZ-RECIO S, Grijota-Camino MD, Guardiola J, Juanola X, et al
    Prevention of Tuberculosis in Patients Treated With Biological Therapies: Twenty Years' Experience in a Specialised Tuberculosis Clinic in a Low-prevalence Country.
    Clin Infect Dis. 2025 Sep 5:ciaf491. doi: 10.1093.
    >> Share

  28. ARRIAGA MB, Amorim G, Figueiredo MC, Staats C, et al
    Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts.
    Clin Infect Dis. 2025 Sep 3:ciaf475. doi: 10.1093.
    >> Share

    August 2025
  29. LAW S, Fulcher I, Ashraf S, Bastard M, et al
    Characterizing treatment adherence trajectories in the endTB multisite cohort of drug-resistant tuberculosis patients: an application of group-based trajectory modelling.
    Clin Infect Dis. 2025 Aug 22:ciaf467. doi: 10.1093.
    >> Share

  30. POORE H, Wambi P, Nkereuwem E, Nakafeero J, et al
    The three-gene Xpert Host Response signature for pediatric tuberculosis screening: A prospective diagnostic accuracy study.
    Clin Infect Dis. 2025 Aug 21:ciaf445. doi: 10.1093.
    >> Share

  31. SINHA P, Bhargava M, Dauphinais MR, Carwile ME, et al
    In-kind Nutritional Supplementation for Persons With Drug-susceptible Tuberculosis and Their Household Contacts Would be Cost-effective for Reducing Tuberculosis Incidence and Mortality in Jharkhand, India: A Modeling Study.
    Clin Infect Dis. 2025 Aug 20:ciaf400. doi: 10.1093.
    >> Share

  32. BISIMWA BC, Kiselinova M, Cuella I, Rigouts L, et al
    Retrospective Cohort Analysis for Identification of Discordant Rifampicin-resistant Xpert MTB/RIF Assay Results in South Kivu, Eastern Democratic Republic of the Congo, a High Burden Tuberculosis Setting.
    Clin Infect Dis. 2025 Aug 12:ciaf451. doi: 10.1093.
    >> Share

  33. CHURCHYARD GJ, Swindells S, Gupta A, Shah NS, et al
    Preventing multidrug resistant tuberculosis: the dawn of a new era.
    Clin Infect Dis. 2025 Aug 7:ciaf426. doi: 10.1093.
    >> Share

  34. CHELI S, Torre A, Schiuma M, Montrasio C, et al
    NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study.
    Clin Infect Dis. 2025;81:145-152.
    >> Share

    July 2025
  35. MURRAY MB, Madden AE, Ofori SK
    Harmonization of Study Design and Reporting for Chronic Pulmonary Aspergillosis in Tuberculosis Patients.
    Clin Infect Dis. 2025 Jul 30:ciaf309. doi: 10.1093.
    >> Share

  36. BEZUIDENHOUT C, Long L, Nichols B, Meyer-Rath G, et al
    Sputum and tongue swab molecular testing for the in-home diagnosis of tuberculosis in unselected household contacts: a cost and cost-effectiveness analysis.
    Clin Infect Dis. 2025 Jul 24:ciaf389. doi: 10.1093.
    >> Share

  37. LIU W, He T, Zhan S, Qin H, et al
    Safety, feasibility and rifapentine plasma concentration in Chinese children with 1 month of daily rifapentine plus isoniazid for tuberculosis infection.
    Clin Infect Dis. 2025 Jul 21:ciaf404. doi: 10.1093.
    >> Share

  38. ROCKMAN L, Abdulgader SM, Minnies S, Palmer Z, et al
    Oral washes and tongue swabs for Xpert MTB/RIF Ultra-based tuberculosis diagnosis in people with and without the ability to make sputum.
    Clin Infect Dis. 2025 Jul 18:ciaf397. doi: 10.1093.
    >> Share

  39. ANDREWS JR, Kendall EA, Cattamanchi A, Denkinger CM, et al
    Projecting the impact and costs of near point-of-care tuberculosis screening assays in community-based active case finding.
    Clin Infect Dis. 2025 Jul 17:ciaf395. doi: 10.1093.
    >> Share

  40. MACLEAN EL, Pham YN, Pham CD, Nguyen BC, et al
    Long-term outcomes among people with multi-drug resistant tuberculosis in Vietnam: a prospective cohort study.
    Clin Infect Dis. 2025 Jul 9:ciaf363. doi: 10.1093.
    >> Share

  41. LI Y, Zhang Y, Song L, Cai C, et al
    A Short, All-Oral Regimen for Pre-Extensively Drug-Resistant Tuberculosis: A Multicenter Open-label Single-arm Study.
    Clin Infect Dis. 2025 Jul 8:ciaf351. doi: 10.1093.
    >> Share

  42. COX SR, Moe AH, Gupte AN, Kadam A, et al
    A point-of-care prediction tool for recurrent tuberculosis.
    Clin Infect Dis. 2025 Jul 8:ciaf353. doi: 10.1093.
    >> Share

    June 2025
  43. TUGUME L, Cresswell FV, Engen NW, Tukundane A, et al
    Prognostic Value of C-Reactive Protein in Adults With Tuberculous Meningitis: A Prospective Cohort Study.
    Clin Infect Dis. 2025 Jun 24:ciaf261. doi: 10.1093.
    >> Share

  44. LU X, Jiang Y, Zhang R, Zhang Y, et al
    Epidemiologic and Bacterial Factors Facilitating Long-Term Transmission of Multidrug-Resistant Tuberculosis in Shanghai, China.
    Clin Infect Dis. 2025 Jun 18:ciaf313. doi: 10.1093.
    >> Share

  45. AGARWAL R, Nyendak M, Chava N, Allam RR, et al
    Long-term protection from TB preventive treatment among people with HIV in a high-burden tuberculosis setting: an observational cohort study from India.
    Clin Infect Dis. 2025 Jun 16:ciaf322. doi: 10.1093.
    >> Share

  46. JAGANATH D, Nabeta P, Nicol MP, Castro R, et al
    Stool processing methods for Xpert Ultra testing in childhood tuberculosis: A prospective, multi-country accuracy study.
    Clin Infect Dis. 2025 Jun 3:ciaf289. doi: 10.1093.
    >> Share

  47. DE JAGER V, Mockeliunas L, You H, Simonsson USH, et al
    A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination with Meropenem plus Amoxicillin/Clavulanate Among Adults with Rifampicin-Resistant Pulmonary Tuberculosis.
    Clin Infect Dis. 2025 Jun 2:ciaf276. doi: 10.1093.
    >> Share

    May 2025
  48. PURCHASE SE, Brigden J, Seddon JA, Martinson NA, et al
    Risk of tuberculosis infection in young children exposed to multidrug-resistant tuberculosis in the TB-CHAMP multi-site randomised controlled trial.
    Clin Infect Dis. 2025 May 29:ciaf284. doi: 10.1093.
    >> Share

  49. BONGOMIN F, Denning DW
    Pulmonary Tuberculosis Associated Chronic Pulmonary Aspergillosis: Urgent Need to Standardize Reporting of Prevalence Studies.
    Clin Infect Dis. 2025 May 28:ciaf279. doi: 10.1093.
    >> Share


  50. Correction to: Serial Mass Screening for Tuberculosis Among Incarcerated Persons in Brazil.
    Clin Infect Dis. 2025 May 21:ciaf223. doi: 10.1093.
    >> Share

  51. REGAN JJ, Wang Z, Phares CR
    The Effect of Live-Virus Vaccines on Tests for Tuberculosis Infection During the US Immigration Medical Examination: Are Vaccines Causing False-Negative Results?
    Clin Infect Dis. 2025 May 15:ciaf129. doi: 10.1093.
    >> Share

  52. STADLER JAM, Kuhlin JJ, Molloy SF, Mtwa NN, et al
    Treatment Outcomes With an Oral Short Course Regimen for Rifampicin-resistant Tuberculosis in a High HIV Prevalence, Programmatic Setting in South Africa.
    Clin Infect Dis. 2025 May 9:ciaf112. doi: 10.1093.
    >> Share

  53. CHIANG SS, Campbell JR, Pelissari DM, de Oliveira MCB, et al
    The Impact of Pregnancy on Tuberculosis Treatment Outcomes: An Analysis of Brazilian National Surveillance Data 2016-2022.
    Clin Infect Dis. 2025 May 6:ciaf233. doi: 10.1093.
    >> Share

    April 2025
  54. LARSSON L, Calderwood CJ, Marambire ET, Held K, et al
    Body mass index trajectories and association with tuberculosis risk in a cohort of household contacts in Southern Africa.
    Clin Infect Dis. 2025 Apr 28:ciaf222. doi: 10.1093.
    >> Share

  55. DAHL VN, Pedersen OS, Butova T, Kuzhko M, et al
    Effectiveness of the BPaL(M) Regimen for Drug-Resistant Tuberculosis in Ukraine under Programmatic Conditions.
    Clin Infect Dis. 2025 Apr 25:ciaf214. doi: 10.1093.
    >> Share

  56. KIM S, Pelissari DM, Harada LO, Sanchez M, et al
    Long-term mortality trends among individuals with tuberculosis: a retrospective cohort study of individuals diagnosed with tuberculosis in Brazil.
    Clin Infect Dis. 2025 Apr 18:ciaf206. doi: 10.1093.
    >> Share

  57. SUTHERLAND JS, van der Spuy GD, Shaw JA, Richardson T, et al
    Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study.
    Clin Infect Dis. 2025 Apr 16:ciaf105. doi: 10.1093.
    >> Share

  58. MONTEPIEDRA G, Aaron L, Theron G, McCarthy K, et al
    Hepatotoxicity Among People Living with HIV and Receiving Isoniazid Preventive Therapy in Pregnancy and Postpartum: The Role of Antiretroviral Regimen and Pharmacogenetics.
    Clin Infect Dis. 2025 Apr 16:ciaf198. doi: 10.1093.
    >> Share


  59. Correction to: Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
    Clin Infect Dis. 2025 Apr 4:ciaf174. doi: 10.1093.
    >> Share

  60. STEAD D, Wasserman S, Steenkamp E, Parrish A, et al
    Comparative Performance of Urine Lipoarabinomannan and Urine Xpert MTB/RIF Ultra for Diagnosing Tuberculosis in Adult Inpatients With Human Immunodeficiency Virus in East London, South Africa.
    Clin Infect Dis. 2025 Apr 2:ciaf080. doi: 10.1093.
    >> Share

    March 2025
  61. BARTL L, Zeeb M, Kalin M, Loosli T, et al
    Machine Learning-Based Prediction of Active Tuberculosis in People with HIV using Clinical Data.
    Clin Infect Dis. 2025 Mar 25:ciaf149. doi: 10.1093.
    >> Share

  62. ADZEMOVIC T, Nalintya E, Fieberg A, Mande E, et al
    Diagnostic Accuracy of the Updated FujiLAM II Assay to Detect Tuberculosis in Outpatients With Advanced HIV Disease.
    Clin Infect Dis. 2025 Mar 25:ciaf079. doi: 10.1093.
    >> Share

  63. PRODANUK M, Silverberg SL, Piche-Renaud PP, Farrar DS, et al
    Adverse events of first-line therapy for pediatric tuberculosis: A systematic review and meta-analysis.
    Clin Infect Dis. 2025 Mar 24:ciaf152. doi: 10.1093.
    >> Share

  64. CUELLA-MARTIN I, Hakizayezu F, Ahmed A, Runyambo D, et al
    Paucibacillary tuberculosis drives the low positive predictive value of Xpert MTB/RIF Ultra for rifampicin resistance detection in low-prevalence settings.
    Clin Infect Dis. 2025 Mar 22:ciaf132. doi: 10.1093.
    >> Share

  65. MADDEN A, Ofori SK, Budu M, Sisay E, et al
    A systematic review of chronic pulmonary aspergillosis among patients treated for pulmonary tuberculosis.
    Clin Infect Dis. 2025 Mar 21:ciaf150. doi: 10.1093.
    >> Share

  66. SODEKE O, Shah NS, Pals S, Riabokon S, et al
    Lower Tuberculosis Incidence Among People With Human Immunodeficiency Virus Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study.
    Clin Infect Dis. 2025 Mar 18:ciaf069. doi: 10.1093.
    >> Share

  67. SINGLA R, Khan S, Silsarma A, Chavan V, et al
    Bedaquiline Resistance and Treatment Outcomes Among Patients With Tuberculosis Previously Exposed to Bedaquiline in India: A Multicentric Retrospective Cohort Study.
    Clin Infect Dis. 2025 Mar 13:ciaf068. doi: 10.1093.
    >> Share

    February 2025
  68. JASWAL MR, Martinez L, Brooks M, Farooq S, et al
    Tuberculosis preventive treatment for household contacts at health facility and community settings in Pakistan.
    Clin Infect Dis. 2025 Feb 27:ciaf088. doi: 10.1093.
    >> Share

  69. SWARTWOOD NA, Cohen T, Marks SM, Hill AN, et al
    Effects of the COVID-19 pandemic on TB outcomes in the United States: a Bayesian analysis.
    Clin Infect Dis. 2025 Feb 27:ciaf092. doi: 10.1093.
    >> Share

  70. TZELIOS CA, Malatesta S, Carney T, White LF, et al
    Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis.
    Clin Infect Dis. 2025 Feb 20:ciae642. doi: 10.1093.
    >> Share

  71. SINHA A, Klebe R, Rekart ML, Alvarez JL, et al
    The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)-Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings-A Prospective Cohort Study in Belarus and Uzbekistan.
    Clin Infect Dis. 2025 Feb 18:ciaf035. doi: 10.1093.
    >> Share

  72. MUNSIFF SS
    American Thoracic Society/Centers for Disease Control and Prevention/European Respiratory Society/Infectious Diseases Society of America (ATS/CDC/ERS/IDSA) Updated guideline on the treatment of tuberculosis.
    Clin Infect Dis. 2025 Feb 14:ciaf066. doi: 10.1093.
    >> Share

    January 2025
  73. MARANCHICK N, Peloquin CA, Haley CA
    Linezolid Dosing and Pharmacokinetics in North American Patients with Tuberculosis.
    Clin Infect Dis. 2025 Jan 21:ciaf027. doi: 10.1093.
    >> Share

  74. ESPINOSA-PEREIRO J, Aguiar A, Nara E, Medina A, et al
    Safety, Efficacy and Pharmacokinetics of daily optimised doses of Rifampicin for the Treatment of Tuberculosis: A Systematic Review and Bayesian Network Meta-Analysis.
    Clin Infect Dis. 2025 Jan 10:ciaf003. doi: 10.1093.
    >> Share

  75. ARBIV OA, Holmes T, Kim MJ, Yan M, et al
    Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2025 Jan 9:ciaf004. doi: 10.1093.
    >> Share

    December 2024
  76. MACPHERSON L, Kik SV, Quartagno M, Lakay F, et al
    Diagnostic Accuracy of Chest X-ray Computer-Aided Detection Software for Detection of Prevalent and Incident Tuberculosis in Household Contacts.
    Clin Infect Dis. 2024 Dec 18:ciae528. doi: 10.1093.
    >> Share

  77. AUMA E, Alberts R, Derendinger B, Venter R, et al
    Diagnostic accuracy of LiquidArray MTB-XDR VER1.0 for the detection of Mycobacterium tuberculosis complex, fluoroquinolone, amikacin, ethambutol, and linezolid susceptibility.
    Clin Infect Dis. 2024 Dec 12:ciae614. doi: 10.1093.
    >> Share

  78. KHAN U, Rich M, Franke M, Lachenal N, et al
    The Frequency and Incidence of QT Prolongation with Extended Use of Bedaquiline or Delamanid in a Large, Multi-Country MDR/RR-TB Cohort.
    Clin Infect Dis. 2024 Dec 10:ciae601. doi: 10.1093.
    >> Share

  79. ZHU Y, Forsman LD, Chen C, Zhang H, et al
    Reply to He et al: Established Association Between Glycemic Control and Anti-Tuberculosis Drug Exposures After Controlling Confounding Effects.
    Clin Infect Dis. 2024 Dec 9:ciae533. doi: 10.1093.
    >> Share

  80. CHEN J, Xie X, Zhang A, He Y, et al
    Is There a Genuine Correlation Between Blood Glucose Control and Anti-tuberculosis Drug Concentrations, or Is it Merely an Illusion?
    Clin Infect Dis. 2024 Dec 9:ciae532. doi: 10.1093.
    >> Share

    November 2024
  81. PUYAT JH, Brode SK, Shulha H, Romanowski K, et al
    Predicting risk of tuberculosis disease in people migrating to a low-TB incidence country: development and validation of a multivariable dynamic risk prediction model using health administrative data.
    Clin Infect Dis. 2024 Nov 20:ciae561. doi: 10.1093.
    >> Share

  82. ROSEN LV, Thielking AM, Dugdale CM, Montepiedra G, et al
    Tuberculosis Preventive Treatment for Pregnant People With Human Immunodeficiency Virus in South Africa: A Modeling Analysis of Clinical Benefits and Risks.
    Clin Infect Dis. 2024 Nov 15:ciae508. doi: 10.1093.
    >> Share

  83. FERRAN E, Chan C, Sheikh N, Dedicoat M, et al
    Population-level frequency of fluoroquinolone resistance by whole-genome sequencing drug predictions in Mycobacterium tuberculosis complex isolates in England from 2017-2023.
    Clin Infect Dis. 2024 Nov 13:ciae560. doi: 10.1093.
    >> Share

  84. PU J, Wu S, He JQ
    Efficacy and Safety of Systematic Corticosteroids treatment among HIV-Positive Patients with Tuberculosis: a systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2024 Nov 11:ciae563. doi: 10.1093.
    >> Share

  85. CRITCHLEY JA, Limb ES, Khakharia A, Carey IM, et al
    Tuberculosis and increased incidence of cardiovascular disease: Cohort study using US and UK health records.
    Clin Infect Dis. 2024 Nov 4:ciae538. doi: 10.1093.
    >> Share

    October 2024
  86. BROOKS JT, Solans BP, Beranger A, Schaaf HS, et al
    Linezolid Pharmacokinetic-Anemia Modeling in Children with Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2024 Oct 18:ciae497. doi: 10.1093.
    >> Share

  87. NATHAVITHARANA RR, Pearl A, Biewer A, Young L, et al
    Effects of respiratory isolation for tuberculosis to reduce community-based transmission: a systematic review.
    Clin Infect Dis. 2024 Oct 14:ciae496. doi: 10.1093.
    >> Share

  88. VIRDEE AK, Knudtzen FC, Llibre JM, Omland LH, et al
    Risk of tuberculosis after achieving HIV virological suppression on antiretroviral therapy: a Danish nationwide prospective cohort study.
    Clin Infect Dis. 2024 Oct 8:ciae499. doi: 10.1093.
    >> Share

    September 2024
  89. SEIFERT M, Catanzaro DG, Gracia M, Hillery N, et al
    Prospective exploratory evaluation of Cepheid Xpert Mycobacterium tuberculosis host response cartridge: a focus on adolescents and young adults.
    Clin Infect Dis. 2024 Sep 5:ciae461. doi: 10.1093.
    >> Share

    August 2024
  90. PADMAPRIYADARSINI C, Oswal VS, Jain CD, Mariappan MV, et al
    Effectiveness and Safety of Varying Doses of Linezolid With Bedaquiline and Pretomanid in Treatment of Drug-Resistant Pulmonary Tuberculosis: Open-Label, Randomized Clinical Trial.
    Clin Infect Dis. 2024 Aug 28:ciae388. doi: 10.1093.
    >> Share

  91. BOSMAN S, Ayakaka I, Muhairwe J, Kamele M, et al
    Evaluation of C-Reactive Protein and Computer-Aided Analysis of Chest X-rays as Tuberculosis Triage Tests at Health Facilities in Lesotho and South Africa.
    Clin Infect Dis. 2024 Aug 27:ciae378. doi: 10.1093.
    >> Share

    July 2024
  92. JARRETT BA, Shearer K, Motlhaoleng K, Chon S, et al
    Comparison of QuantiFERON Gold In-Tube Versus Tuberculin Skin Tests on the Initiation of Tuberculosis Preventive Therapy Among Patients Newly Diagnosed With Human Immunodeficiency Virus in the North West Province of South Africa (the Teko Study): A Cl
    Clin Infect Dis. 2024 Jul 22:ciae268. doi: 10.1093.
    >> Share

  93. PRAKASH BABU S, Ezhumalai K, Raghupathy K, Karoly M, et al
    Factors associated with unfavourable treatment outcomes among persons with Pulmonary Tuberculosis: a multicentric prospective cohort study from India.
    Clin Infect Dis. 2024 Jul 11:ciae367. doi: 10.1093.
    >> Share

  94. WANG MS, Li-Hunnam J, Chen YL, Gilmour B, et al
    Conversion or reversion of interferon gamma release assays for Mycobacterium tuberculosis infection: a systematic review and meta-analysis.
    Clin Infect Dis. 2024 Jul 2:ciae357. doi: 10.1093.
    >> Share

    June 2024
  95. ZHU Y, Forsman LD, Chen C, Zhang H, et al
    Drug exposure and treatment outcomes in patients with multidrug resistant tuberculosis and diabetes mellitus: A multicenter prospective cohort study from China.
    Clin Infect Dis. 2024 Jun 24:ciae329. doi: 10.1093.
    >> Share

  96. RICHTERMAN A, Saintilien E, St-Cyr M, Claudia Gracia L, et al
    Food Insecurity at Tuberculosis Treatment Initiation Is Associated With Clinical Outcomes in Rural Haiti: A Prospective Cohort Study.
    Clin Infect Dis. 2024 Jun 18:ciae252. doi: 10.1093.
    >> Share

  97. RASHITOV M, Franke M, Trevisi L, Bekbolatova G, et al
    Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
    Clin Infect Dis. 2024 Jun 4:ciae305. doi: 10.1093.
    >> Share

  98. ABBOTT R, Landsiedel K, Atukunda M, Puryear SB, et al
    Incident Tuberculosis Infection is Associated with Alcohol use in Adults in Rural Uganda.
    Clin Infect Dis. 2024 Jun 2:ciae304. doi: 10.1093.
    >> Share

    May 2024
  99. BURKE RM, Nyirenda SK, Mtenga T, Twabi HH, et al
    Enhanced tuberculosis diagnosis with computer-aided chest X-ray and urine LAM in adults with HIV admitted to hospital (CASTLE study): A cluster randomised trial.
    Clin Infect Dis. 2024 May 15:ciae273. doi: 10.1093.
    >> Share

  100. SHAH NS, Kityo C, Hughes MD, McCarthy C, et al
    Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
    Clin Infect Dis. 2024 May 13:ciae269. doi: 10.1093.
    >> Share

    April 2024
  101. SINHA P, Ezhumalai K, Du X, Ponnuraja C, et al
    Undernourished Household Contacts Are at Increased Risk of Tuberculosis (TB) Disease, but not TB Infection- a Multicenter Prospective Cohort Analysis.
    Clin Infect Dis. 2024 Apr 23:ciae149. doi: 10.1093.
    >> Share

  102. FARHAT MR, Jacobson KR
    For Tuberculosis, Not "To Screen or Not to Screen?" but "Who?" and "How?".
    Clin Infect Dis. 2024 Apr 18:ciae058. doi: 10.1093.
    >> Share

  103. GOSWAMI N, Reed C
    Duration of Effective Tuberculosis Treatment, not Acid-Fast Bacilli (AFB) Smear Status, as the Determinant for Deisolation in Community Settings.
    Clin Infect Dis. 2024 Apr 18:ciae198. doi: 10.1093.
    >> Share

  104. SHAH M, Dansky Z, Nathavitharana R, Behm H, et al
    NTCA Guidelines for Respiratory Isolation and Restrictions to Reduce Transmission of Pulmonary Tuberculosis in Community Settings.
    Clin Infect Dis. 2024 Apr 18:ciae199. doi: 10.1093.
    >> Share

  105. MARINER-LLICER C, Saavedra Cervera B, Mambuque E, Gomes N, et al
    Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique.
    Clin Infect Dis. 2024;78:842-845.
    >> Share

  106. MIKIASHVILI L, Kempker RR, Chakhaia TS, Bablishvili N, et al
    Impact of Prior Tuberculosis Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for Multidrug- and Rifampicin-Resistant Tuberculosis.
    Clin Infect Dis. 2024;78:1043-1052.
    >> Share

  107. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    >> Share

  108. RODRIGUEZ-MOLINO P, Tebruegge M, Noguera-Julian A, Neth O, et al
    Tuberculosis disease in immunocompromised children and adolescents: a pTBnet multi-centre case-control study.
    Clin Infect Dis. 2024 Apr 3:ciae158. doi: 10.1093.
    >> Share

  109. PODANY AT, Cramer Y, Imperial M, Rosenkranz SL, et al
    Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
    Clin Infect Dis. 2024 Apr 3:ciae183. doi: 10.1093.
    >> Share

    March 2024
  110. BERTUMEN JB, Pascopella L, Han E, Glenn-Finer R, et al
    Epidemiology and Treatment Outcomes of Tuberculosis with Chronic Hepatitis B Infection-California, 2016-2020.
    Clin Infect Dis. 2024 Mar 26:ciae169. doi: 10.1093.
    >> Share

  111. MORGAN H, Ndjeka N, Hasan T, Gegia M, et al
    Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study.
    Clin Infect Dis. 2024 Mar 25:ciae145. doi: 10.1093.
    >> Share

  112. SUNSTRUM J, Power LE, Fligiel HM, Lauter C, et al
    Human Disease due to Mycobacterium bovis Linked to Free-Ranging Deer in Michigan.
    Clin Infect Dis. 2024;78:637-645.
    >> Share

  113. KRISHNAN S, Chaisson RE
    US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
    Clin Infect Dis. 2024;78:514-517.
    >> Share

  114. NGO HX, Xu AY, Velasquez GE, Zhang N, et al
    Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
    Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093.
    >> Share

    February 2024
  115. CROCKER-BUQUE T, Lachenal N, Narasimooloo C, Abdrasuliev T, et al
    Pregnancy Outcomes in Multidrug-Resistant Tuberculosis in TB-PRACTECAL.
    Clin Infect Dis. 2024 Feb 29:ciad767. doi: 10.1093.
    >> Share

  116. TEIXEIRA LAA, Santos B, Correia MG, Valiquette C, et al
    Long-term protective effect of tuberculosis preventive therapy in a medium/high TB incidence setting.
    Clin Infect Dis. 2024 Feb 26:ciae101. doi: 10.1093.
    >> Share

  117. WHITE YN, Solans BP, Denti P, van der Laan LE, et al
    Pharmacokinetics and Optimal Dosing of Levofloxacin in Children for Drug-Resistant Tuberculosis: An Individual Patient Data Meta-Analysis.
    Clin Infect Dis. 2024 Feb 10:ciae024. doi: 10.1093.
    >> Share

  118. PIVETTA DE ARAUJO RC, Martinez L, da Silva Santos A, Ferreira Lemos E, et al
    Serial Mass Screening for Tuberculosis among Incarcerated Persons in Brazil.
    Clin Infect Dis. 2024 Feb 7:ciae055. doi: 10.1093.
    >> Share

  119. STEADMAN A, Andama A, Ball A, Mukwatamundu J, et al
    New manual qPCR assay validated on tongue swabs collected and processed in Uganda shows sensitivity that rivals sputum-based molecular TB diagnostics.
    Clin Infect Dis. 2024 Feb 2:ciae041. doi: 10.1093.
    >> Share

    January 2024
  120. MARQUEZ C, Atukunda M, Nugent J, Charlebois ED, et al
    Community-Wide Universal Human Immunodeficiency Virus (HIV) Test and Treat Intervention Reduces Tuberculosis Transmission in Rural Uganda: A Cluster-Randomized Trial.
    Clin Infect Dis. 2024 Jan 16:ciad776. doi: 10.1093.
    >> Share

  121. KU JH, Fischer H, Qian LX, Li K, et al
    Latent tuberculosis infection testing practices in a large U.S. integrated healthcare system.
    Clin Infect Dis. 2024 Jan 11:ciae015. doi: 10.1093.
    >> Share

  122. GARCIA LS, Costa AG, Araujo-Pereira M, Spener-Gomes R, et al
    The Xpert(R) MTB/RIF cycle threshold value predicts M. tuberculosis transmission to close contacts in a Brazilian prospective multicenter cohort.
    Clin Infect Dis. 2024 Jan 3:ciad794. doi: 10.1093.
    >> Share

  123. LINDE L, Brooks MB, Martinez L
    Beyond Diagnosis: Xpert Cycle Threshold Values as Predictors of Tuberculosis Transmission.
    Clin Infect Dis. 2024 Jan 3:ciad791. doi: 10.1093.
    >> Share

    December 2023
  124. LIN KY, Sun HY, Yang CJ, Lu PL, et al
    Treatment responses to integrase strand-transfer inhibitor-containing antiretroviral regimens in combination with short-course rifapentine-based regimens for latent tuberculosis infection among people with HIV.
    Clin Infect Dis. 2023 Dec 5:ciad730. doi: 10.1093.
    >> Share

    November 2023
  125. SCHWALB A, Kayumba K, Houben RMGJ, Bothamley GH, et al
    Recent travel and tuberculosis in migrants: data from a low incidence country.
    Clin Infect Dis. 2023 Nov 6:ciad672. doi: 10.1093.
    >> Share

  126. LIU X, Xia L, Wang X, Huang Z, et al
    Treatment Outcomes in Multidrug-Resistant Tuberculosis During Pregnancy.
    Clin Infect Dis. 2023 Nov 1:ciad594. doi: 10.1093.
    >> Share

    October 2023
  127. BROWN TS, Tang L, Omar SV, Joseph L, et al
    Genotype-Phenotype Characterization of Serial Mycobacterium tuberculosis Isolates in Bedaquiline-Resistant Tuberculosis.
    Clin Infect Dis. 2023 Oct 24:ciad596. doi: 10.1093.
    >> Share

  128. HASAN T, Medcalf E, Nyang'wa BT, Egizi E, et al
    The safety and tolerability of linezolid in novel short-course regimens containing bedaquiline, pretomanid and linezolid to treat rifampicin-resistant tuberculosis: an individual patient data meta-analysis.
    Clin Infect Dis. 2023 Oct 24:ciad653. doi: 10.1093.
    >> Share

  129. KHAN AR, Tirlangi PK, Wig N, Soneja M, et al
    Immortal Time Bias for Infliximab in Central Nervous System Tuberculosis.
    Clin Infect Dis. 2023 Oct 13:ciad590. doi: 10.1093.
    >> Share

  130. SUNG J, Nantale M, Nalutaaya A, Biche P, et al
    Evidence for tuberculosis in individuals with Xpert Ultra "trace" sputum during screening of high-burden communities.
    Clin Infect Dis. 2023 Oct 3:ciad595. doi: 10.1093.
    >> Share

    September 2023
  131. SAUER SM, Mitnick CD, Khan U, Hewison C, et al
    Estimating post-treatment recurrence after multidrug-resistant tuberculosis treatment among patients with and without HIV: the impact of assumptions about death and missing follow-up.
    Clin Infect Dis. 2023 Sep 29:ciad589. doi: 10.1093.
    >> Share

  132. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
    Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
    Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
    >> Share

  133. KASAIE P, Pennington J, Gupta A, Dowdy DW, et al
    The impact of preventive treatment for multidrug- and rifampin-resistant tuberculosis exceeds trial-based estimates.
    Clin Infect Dis. 2023 Sep 19:ciad557. doi: 10.1093.
    >> Share

  134. BOAST A, How JA, Lau C, Sett A, et al
    Pre-XDR congenital tuberculosis in an extremely premature baby.
    Clin Infect Dis. 2023 Sep 8:ciad540. doi: 10.1093.
    >> Share

    August 2023
  135. BRUMMER LE, Thompson RR, Malhotra A, Shrestha S, et al
    Cost effectiveness of low-complexity screening tests in community-based case-finding for tuberculosis.
    Clin Infect Dis. 2023 Aug 25:ciad501. doi: 10.1093.
    >> Share

  136. LOTIA FARRUKH I, Lachenal N, Adenov MM, Ahmed S, et al
    Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
    Clin Infect Dis. 2023 Aug 22:ciad445. doi: 10.1093.
    >> Share

  137. SULIMAN S, Jaganath D, DiNardo A
    Predicting Pediatric Tuberculosis: The Need for Age-Specific Host Biosignatures.
    Clin Infect Dis. 2023;77:450-452.
    >> Share

  138. WALLES J, Winqvist N, Hansson SR, Sturegard E, et al
    Pregnancy outcomes in women screened for tuberculosis infection in Swedish antenatal care.
    Clin Infect Dis. 2023 Aug 12:ciad465. doi: 10.1093.
    >> Share

  139. BROUGH J, Martinez L, Hatherill M, Zar HJ, et al
    Public health impact and cost-effectiveness of screening for active tuberculosis disease or infection among children in South Africa.
    Clin Infect Dis. 2023 Aug 5:ciad449. doi: 10.1093.
    >> Share

    July 2023
  140. HU Z, Liu K, Zhou M, Jiang X, et al
    Mass tuberculosis screening among the elderly: A population-based study in a well-confined rural county in eastern China.
    Clin Infect Dis. 2023 Jul 28:ciad438. doi: 10.1093.
    >> Share

  141. WINGFIELD T
    Ending tuberculosis in older people: new strategies for an age-old disease.
    Clin Infect Dis. 2023 Jul 28:ciad439. doi: 10.1093.
    >> Share

  142. ACUNA-VILLAORDUNA C, Fennelly KP, Jones-Lopez EC
    Aerosol Sampling Outperforms Sputum to Predict Mycobacterium tuberculosis Transmission.
    Clin Infect Dis. 2023 Jul 18:ciad372. doi: 10.1093.
    >> Share

  143. S AM, Gautam P, D SSK, Mannam P, et al
    Effectiveness of adjunctive high dose infliximab therapy to improve disability free survival among patients with severe CNS tuberculosis: a matched retrospective cohort study.
    Clin Infect Dis. 2023 Jul 5:ciad401. doi: 10.1093.
    >> Share

    June 2023
  144. MOON SM, Choi H, Kim SH, Kang HK, et al
    Increased lung cancer risk and associated risk factors in tuberculosis survivors: A Korean population-based study.
    Clin Infect Dis. 2023 Jun 22:ciad373. doi: 10.1093.
    >> Share

  145. LUCZYNSKI P, Holmes T, Romanowski K, Arbiv OA, et al
    Risk of tuberculosis disease in people with chronic kidney disease without kidney failure: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Jun 13:ciad364. doi: 10.1093.
    >> Share

  146. IWASE SC, Edlefsen PT, Bhebhe L, Motsumi K, et al
    T-SPOT.TB reactivity in Southern African children with and without in utero HIV exposure.
    Clin Infect Dis. 2023 Jun 9:ciad356. doi: 10.1093.
    >> Share

  147. SOLANS BP, Imperial MZ, Olugbosi M, Savic RM, et al
    Analysis of Dynamic Efficacy Endpoints of the Nix-TB Trial.
    Clin Infect Dis. 2023;76:1903-1910.
    >> Share

    May 2023
  148. ZEEB M, Tepekule B, Kusejko K, Reiber C, et al
    Understanding the decline of incident, active tuberculosis in people with HIV in Switzerland.
    Clin Infect Dis. 2023 May 31:ciad330. doi: 10.1093.
    >> Share

  149. HALEY CA, Schechter MC, Ashkin D, Peloquin CA, et al
    Implementation of BPaL in the United States: Experience using a novel all-oral treatment regimen for treatment of rifampin-resistant or rifampin-intolerant TB disease.
    Clin Infect Dis. 2023 May 30:ciad312. doi: 10.1093.
    >> Share

  150. AHSBERG J, Puplampu P, Kwashie A, Commey JO, et al
    Point-of-care urine LAM testing to guide tuberculosis treatment among severely ill in-patients with HIV in real-world practice: a multi-center stepped wedge cluster-randomized trial from Ghana.
    Clin Infect Dis. 2023 May 26:ciad316. doi: 10.1093.
    >> Share

  151. KRISHNAN S, Wu X, Kim S, McIntire K, et al
    One-year incidence of tuberculosis infection and disease among household contacts of rifampin- and multi-drug resistant tuberculosis.
    Clin Infect Dis. 2023 May 25:ciad301. doi: 10.1093.
    >> Share

  152. ROMANOWSKI K, Law MR, Karim ME, Campbell JR, et al
    Healthcare utilization after respiratory tuberculosis: a controlled interrupted time series analysis.
    Clin Infect Dis. 2023 May 9:ciad290. doi: 10.1093.
    >> Share

  153. BOBAK CA, Botha M, Workman L, Hill JE, et al
    Gene expression in cord blood and tuberculosis in early childhood: A nested case-control study in a South African birth cohort.
    Clin Infect Dis. 2023 May 5:ciad268. doi: 10.1093.
    >> Share

  154. TIMIRE C, Pedrazzoli D, Boccia D, Houben RM, et al
    Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds.
    Clin Infect Dis. 2023 May 3:ciad273. doi: 10.1093.
    >> Share

  155. LOUIE JK, Keh C
    Latent Tuberculosis Infection Treatment: Still a Long Road Ahead.
    Clin Infect Dis. 2023 May 1:ciad251. doi: 10.1093.
    >> Share

  156. MELNYCHUK L, Perlman-Arrow S, Bastos M, Menzies D, et al
    A Systematic Review and Meta-Analysis of Tuberculous Preventative Therapy Adverse Events.
    Clin Infect Dis. 2023 May 1:ciad246. doi: 10.1093.
    >> Share

    April 2023
  157. BURKE RM, Nliwasa M, Dodd PJ, Feasey HR, et al
    Impact of community-wide tuberculosis active case finding and HIV testing on tuberculosis trends in Malawi.
    Clin Infect Dis. 2023 Apr 26:ciad238. doi: 10.1093.
    >> Share

  158. CHAISSON LH
    Finding tuberculosis: More evidence for community-wide systematic screening.
    Clin Infect Dis. 2023 Apr 26:ciad232. doi: 10.1093.
    >> Share

  159. HUSSAIN H, Jaswal M, Farooq S, Safdar N, et al
    Scale up of rifapentine-isoniazid (3HP) for tuberculosis prevention amongst household contacts in two urban centers: An effectiveness assessment.
    Clin Infect Dis. 2023 Apr 21:ciad245. doi: 10.1093.
    >> Share

  160. SABET N, Omar T, Milovanovic M, Magajane T, et al
    Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study.
    Clin Infect Dis. 2023 Apr 12:ciad212. doi: 10.1093.
    >> Share

    March 2023
  161. UPTON CM, Wiesner L, Dooley KE, Maartens G, et al
    Cerebrospinal Fluid and Tuberculosis Meningitis.
    Clin Infect Dis. 2023 Mar 29:ciad186. doi: 10.1093.
    >> Share

  162. ALLARD-GRAY A, Boakye I, Camara A, Eisenbeis L, et al
    Factors Associated with Discontinuation of Tuberculosis Preventive Treatment: Post-Hoc Analysis of Two Randomized Controlled Trials.
    Clin Infect Dis. 2023 Mar 23:ciad164. doi: 10.1093.
    >> Share

  163. BONNET M, Gabillard D, Domoua S, Muzoora C, et al
    High performance of systematic combined urine LAM test and sputum Xpert MTB/RIF(R) for tuberculosis screening in severely immunosuppressed ambulatory adults with HIV.
    Clin Infect Dis. 2023 Mar 8:ciad125. doi: 10.1093.
    >> Share

  164. LIU Q, You N, Wen J, Wang J, et al
    Yield and efficiency of a population-based mass tuberculosis screening intervention among persons with diabetes in Jiangsu Province, China.
    Clin Infect Dis. 2023 Mar 3:ciad118. doi: 10.1093.
    >> Share

    December 2022
  165. DAVIS AG, Wasserman S, Stek C, Maxebengula M, et al
    A phase 2A trial of the safety and tolerability of increased dose rifampicin and adjunctive linezolid, with or without aspirin, for HIV-associated tuberculous meningitis (The LASER-TBM Trial).
    Clin Infect Dis. 2022 Dec 9:ciac932. doi: 10.1093.
    >> Share

    October 2022
  166. DAVIS AG, Dreyer AJ, Albertyn C, Maxebengula M, et al
    Cognitive Impairment in Tuberculous Meningitis.
    Clin Infect Dis. 2022 Oct 20. pii: 6763738. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016